DK3589728T3 - Naturlige dræberceller - Google Patents

Naturlige dræberceller Download PDF

Info

Publication number
DK3589728T3
DK3589728T3 DK18710125.8T DK18710125T DK3589728T3 DK 3589728 T3 DK3589728 T3 DK 3589728T3 DK 18710125 T DK18710125 T DK 18710125T DK 3589728 T3 DK3589728 T3 DK 3589728T3
Authority
DK
Denmark
Prior art keywords
natural killer
killer cells
cells
natural
killer
Prior art date
Application number
DK18710125.8T
Other languages
English (en)
Inventor
Hugh J M Brady
Matthew Fuchter
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Application granted granted Critical
Publication of DK3589728T3 publication Critical patent/DK3589728T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK18710125.8T 2017-03-03 2018-03-02 Naturlige dræberceller DK3589728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1703476.0A GB201703476D0 (en) 2017-03-03 2017-03-03 Natural killer cells
PCT/GB2018/050542 WO2018158587A1 (en) 2017-03-03 2018-03-02 Natural killer cells

Publications (1)

Publication Number Publication Date
DK3589728T3 true DK3589728T3 (da) 2022-09-19

Family

ID=58544022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18710125.8T DK3589728T3 (da) 2017-03-03 2018-03-02 Naturlige dræberceller

Country Status (8)

Country Link
US (2) US11559547B2 (da)
EP (2) EP4137563A1 (da)
JP (2) JP7225107B2 (da)
DK (1) DK3589728T3 (da)
ES (1) ES2928879T3 (da)
GB (1) GB201703476D0 (da)
PT (1) PT3589728T (da)
WO (1) WO2018158587A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201810486D0 (en) * 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells
CN114907333B (zh) * 2022-05-11 2023-07-04 中国人民解放军军事科学院军事医学研究院 环丙甲酰胺衍生物及其制备方法和用途
EP4581132A1 (en) * 2022-09-02 2025-07-09 Imperial College Innovations Limited Natural killer cells
WO2025215203A1 (en) * 2024-04-12 2025-10-16 Institut National de la Santé et de la Recherche Médicale Use of rev-erb antagonists for the treatment of lung infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9121008B2 (en) 2005-08-31 2015-09-01 University Of Utah Research Foundation Development of natural killer cells and functional natural killer cell lines
US20100267803A1 (en) * 2008-11-07 2010-10-21 The Research Foundation Of State University Of New York Regulators Of Fat Metabolism As Anti-Cancer Targets
US20130011376A1 (en) 2009-12-29 2013-01-10 Gamida Cell Ltd. Methods for Enhancing Natural Killer Cell Proliferation and Activity
EP2686421B1 (en) 2011-03-18 2020-12-23 Glycostem Therapeutics B.V. Generation of nk cells and nk-cell progenitors
WO2013033310A1 (en) 2011-08-31 2013-03-07 Theodore Mark Kamenecka Modulators of rev-erb
US20130330279A1 (en) * 2012-06-09 2013-12-12 Nnanoaxis, Llc Nanoparticle mediated gene therapy, diagnostic products and therapeutic products for breast cancer
ITTO20130816A1 (it) 2013-10-09 2015-04-10 Fond Istituto Italiano Di Tecnologia Antagonisti di rev-erb diarilalchilaminici e loro uso come farmaci
WO2015103527A1 (en) 2014-01-06 2015-07-09 The Scripps Research Institute Modulators of rev-erb
CN105596336B (zh) 2016-01-18 2018-05-22 暨南大学 化合物sr8278在制备治疗i型糖尿病角膜病变药物中的应用
US20180280372A1 (en) * 2016-11-22 2018-10-04 Washington University Compositions and methods for inhibiting autophagy and contraception
GB201704953D0 (en) 2017-03-28 2017-05-10 Imp Innovations Ltd Natural killer cells
GB201810486D0 (en) 2018-06-26 2018-08-08 Imperial Innovations Ltd Natural killer cells

Also Published As

Publication number Publication date
EP4137563A1 (en) 2023-02-22
ES2928879T3 (es) 2022-11-23
GB201703476D0 (en) 2017-04-19
JP2020510431A (ja) 2020-04-09
US20230330145A1 (en) 2023-10-19
US12496298B2 (en) 2025-12-16
EP3589728B1 (en) 2022-09-07
PT3589728T (pt) 2022-09-16
WO2018158587A1 (en) 2018-09-07
EP3589728A1 (en) 2020-01-08
US20190381102A1 (en) 2019-12-19
US11559547B2 (en) 2023-01-24
JP7225107B2 (ja) 2023-02-20
JP2023025190A (ja) 2023-02-21

Similar Documents

Publication Publication Date Title
EP3562492A4 (en) GENETICALLY MODIFIED NATURAL KILLER CELLS
IL258666A (en) Natural killer cells and ilc3 cells and uses thereof
IL271227A (en) Image sensor structure
DK3581190T3 (da) Manipulerede naturlige dræberceller og anvendelser deraf
EP3858365C0 (en) T CAR CELLS OPTIMIZED WITH GOLD
DK3143134T3 (da) Modificerede, naturlige dræberceller og anvendelser deraf
EP4212613C0 (en) CELL GROWTH MATRIX
EP3573464A4 (en) B CELL ENGINEERING
CL2020000951A1 (es) Célula.
EP3443506C0 (fr) Neurone artificiel
UA38793S (uk) Акумуляторна батарея
EP3718392A4 (en) HARVEST MACHINE
EP3358627C0 (en) SOLAR CELL
HUE053760T2 (hu) SUV39h1-deficiens immunsejtek
EP3487471A4 (en) ARTIFICIAL TEAT PROTECTION AGAINST BITES
HUE072082T2 (hu) Akkumulátor
EP3613123A4 (en) PERFORMANCE-BASED BATTERY CONFIGURATIONS
DK3365107T3 (da) Cellekultur
GB201704953D0 (en) Natural killer cells
EP3448986A4 (en) CELL CULTURE
EP3425626A4 (en) REED
GB201810486D0 (en) Natural killer cells
IL270880A (en) Cell culture methods
PT3589728T (pt) Células assassinas naturais
EP3664201A4 (en) FUEL BATTERY CELL